Why this distinction exists at all
When shockwave research is reviewed, one of the most frequent methodological complaints is that radial pressure-wave trials and focused shockwave trials get pooled as though they studied the same intervention. They don't. The waveform, the way energy is generated and the depth profile all differ.
For a patient, the practical consequence is simple: a claim like "shockwave has been proven for this" is incomplete unless it says which kind, at what energy, for which diagnosis.
How radial devices generally work
- A projectile is typically driven pneumatically against an applicator head
- The resulting pressure wave spreads outward from the contact surface
- Energy tends to concentrate in more superficial tissue
- Often used for superficial tendon and soft-tissue or myofascial treatment
How shockwave technologies generally differ
- Acoustic shockwaves are generated by the device rather than by a mechanical projectile impact
- Energy characteristics and coverage are device-specific
- Focused systems converge energy toward a target depth
- Device-specific coverage claims should be verified in the manufacturer's own documentation
What we won't do on this page
We won't claim SoftWave is universally superior to radial therapy, and we won't criticize other technologies. Both categories appear in the literature with results that depend on condition, protocol and energy. What we will say is that the two are not interchangeable and shouldn't be discussed as if they were.
The question that actually changes your outcome
Not "which machine," but "what is wrong, and what is the full plan?" Device choice sits inside that plan. If a clinic leads with the device and never gets to the diagnosis, that's worth noticing.